GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HEXO Corp (NAS:HEXO) » Definitions » EV-to-EBIT

HEXO (HEXO) EV-to-EBIT : -0.72 (As of Apr. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is HEXO EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, HEXO's Enterprise Value is $151.84 Mil. HEXO's EBIT for the trailing twelve months (TTM) ended in Apr. 2023 was $-210.86 Mil. Therefore, HEXO's EV-to-EBIT for today is -0.72.

The historical rank and industry rank for HEXO's EV-to-EBIT or its related term are showing as below:

HEXO' s EV-to-EBIT Range Over the Past 10 Years
Min: -71.51   Med: -4.93   Max: -0.24
Current: -0.71

During the past 9 years, the highest EV-to-EBIT of HEXO was -0.24. The lowest was -71.51. And the median was -4.93.

HEXO's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.125 vs HEXO: -0.71

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. HEXO's Enterprise Value for the quarter that ended in Apr. 2023 was $171.76 Mil. HEXO's EBIT for the trailing twelve months (TTM) ended in Apr. 2023 was $-210.86 Mil. HEXO's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2023 was -122.76%.


HEXO EV-to-EBIT Historical Data

The historical data trend for HEXO's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HEXO EV-to-EBIT Chart

HEXO Annual Data
Trend Sep14 Sep15 Sep16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only -28.07 -15.56 -0.64 -14.31 -0.29

HEXO Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -0.29 -0.33 -0.83 -0.83

Competitive Comparison of HEXO's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, HEXO's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HEXO's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HEXO's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where HEXO's EV-to-EBIT falls into.



HEXO EV-to-EBIT Calculation

HEXO's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=151.841/-210.859
=-0.72

HEXO's current Enterprise Value is $151.84 Mil.
HEXO's EBIT for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-210.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HEXO  (NAS:HEXO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

HEXO's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Apr. 2023 ) =EBIT / Enterprise Value (Q: Apr. 2023 )
=-210.859/171.764644
=-122.76 %

HEXO's Enterprise Value for the quarter that ended in Apr. 2023 was $171.76 Mil.
HEXO's EBIT for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-210.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HEXO EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of HEXO's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


HEXO (HEXO) Business Description

Traded in Other Exchanges
N/A
Address
120 de la Rive Road, Gatineau, QC, CAN, J8M 1V2
HEXO Corp is engaged in producing and selling cannabis and cannabis products. The company is focused on smoke-free and traditional cannabis products. The firm's products include dried flowers, oils, and vapes. It generates its revenue from various sources such as Beverage Based Adult-Use Sales, Medical, Wholesale and International sales.